Related references
Note: Only part of the references are listed.Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis
Marina M. Bellet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis
James F. Chmiel et al.
JOURNAL OF CYSTIC FIBROSIS (2021)
Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis
Benjamin T. Kopp et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis
P. Barth et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Dave P. Nichols et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications
Marcus A. Mall et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Alpha-1 Antitrypsin-A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis
Alison M. D. Hunt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis
Anna Caretti et al.
CELLS (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
Heledd H. Jarosz-Griffiths et al.
ELIFE (2020)
Understanding the renin angiotensin-aldosterone-SARS-CoV axis: a comprehensive review
Nicholas E. Ingraham et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Miqueias Lopes-Pacheco
FRONTIERS IN PHARMACOLOGY (2020)
Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis
Adam J. Causer et al.
REDOX BIOLOGY (2020)
Anti-inflammatory effects of lenabasum, a cannabinoid receptor type 2 agonist, on macrophages from cystic fibrosis
Abdullah A. Tarique et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Asymptomatic case of Covid-19 in an infant with cystic fibrosis
Piercarlo Poli et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
Rebecca Cosgriff et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease Insights From Cardiovascular Aging Science
Majd AlGhatrif et al.
JAMA CARDIOLOGY (2020)
SARS-CoV-2 (COVID-19) and cystic fibrosis
Bruce A. Stanton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
CFTR Modulators DampenAspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes
Alexander J. Currie et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
Christie Mitri et al.
FRONTIERS IN PHARMACOLOGY (2020)
Distinctive lipid signatures of bronchial epithelial cells associated with cystic fibrosis drugs, including Trikafta
Nara Liessi et al.
JCI INSIGHT (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
(R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages
Chandra L. Shrestha et al.
SCIENTIFIC REPORTS (2020)
Pandemic COVID-19: Current status and challenges of antiviral therapies
Winglam Chan et al.
GENES & DISEASES (2020)
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Elliot McClenaghan et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation
J. Kirk Harris et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Novel cystamine-core dendrimer-formulation rescues ΔF508-CFTR and inhibits Pseudomonas aeruginosa infection by augmenting autophagy
Janine Faraj et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis
Charles R. Esther et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling Pathways
Dalia Haydar et al.
JOURNAL OF IMMUNOLOGY (2019)
Bioactive Thymosin Alpha-1 Does Not Influence F508del-CFTR Maturation and Activity
Andrea Armirotti et al.
SCIENTIFIC REPORTS (2019)
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Harry G. M. Heijerman et al.
LANCET (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators
Lucy Perrem et al.
PEDIATRIC PULMONOLOGY (2019)
Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway
Anita Balazs et al.
PEDIATRIC PULMONOLOGY (2019)
Cystic Fibrosis: Pathophysiology of Lung Disease
Christelle Bergeron et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa
Do-Yeon Cho et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2019)
Gene therapy-emulating small molecule treatments in cystic fibrosis airway epithelial cells and patients
Q. Yang et al.
RESPIRATORY RESEARCH (2019)
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis
Larry C. Lands et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Vx-809/Vx-770 treatment reduces inflammatory response to Pseudomonas aeruginosa in primary differentiated cystic fibrosis bronchial epithelial cells
Manon Ruffin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa
Roxanna Barnaby et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
Scott H. Donaldson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study
B. C. Millar et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)
F508del-CFTR is not corrected by thymosin α1
Elizabeth Matthes et al.
NATURE MEDICINE (2018)
Inflammation in cystic fibrosis: An update
Erica A. Roesch et al.
PEDIATRIC PULMONOLOGY (2018)
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
Brittany A. Bruch et al.
PEDIATRIC PULMONOLOGY (2018)
Lung mesenchymal stem cells-derived extracellular vesicles attenuate the inflammatory profile of Cystic Fibrosis epithelial cells
Aida Zulueta et al.
CELLULAR SIGNALLING (2018)
Unmet needs in cystic fibrosis
Bruce K. Rubin
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Peripheral Protein Quality Control as a Novel Drug Target for CFTR Stabilizer
Ryosuke Fukuda et al.
FRONTIERS IN PHARMACOLOGY (2018)
The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model
Martina Gentzsch et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Dominic Keating et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Corticosteroid use and increased CXCR2 levels on leukocytes are associated with lumacaftor/ivacaftor discontinuation in cystic fibrosis patients homozygous for the F508del CFTR mutation
Kerstin Pohl et al.
PLOS ONE (2018)
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage
Shuzhong Zhang et al.
SCIENTIFIC REPORTS (2018)
Ajulemic acid: potential treatment for chronic inflammation
Sumner H. Burstein
PHARMACOLOGY RESEARCH & PERSPECTIVES (2018)
Association of High-Dose Ibuprofen Use, Lung Function Decline, and Long-Term Survival in Children with Cystic Fibrosis
Michael W. Konstan et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
The US Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial
Anthony G. Durmowicz et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR (vol 23, pg 1380, 2016)
A. Tosco et al.
CELL DEATH AND DIFFERENTIATION (2017)
Hypoxia and sterile inflammation in cystic fibrosis airways: mechanisms and potential therapies
Samuel T. Montgomery et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Azithromycin and Chloramphenicol Diminish Neutrophil Extracellular Traps (NETs) Release
Weronika Bystrzycka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
Dave P. Nichols et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Differential Effects of Angelicin Analogues on NF-kappa B Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells
Ilaria Lampronti et al.
MEDIATORS OF INFLAMMATION (2017)
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis
Luigina Romani et al.
NATURE MEDICINE (2017)
Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Jennifer L. Taylor-Cousar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Pseudomonas aeruginosa: Novel Therapeutic Targets to Dampen Inflammation in Cystic Fibrosis
Benoit S. Marteyn et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies
Francisca Alcayaga-Miranda et al.
FRONTIERS IN IMMUNOLOGY (2017)
miRNA-expression in tonsillar squamous cell carcinomas in relation to HPV infection and expression of the antileukoproteinase SLPI
Elgar Susanne Quabius et al.
PAPILLOMAVIRUS RESEARCH (2017)
Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections
Katherine B. Hisert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Ibuprofen regulation of microtubule dynamics in cystic fibrosis epithelial cells
Sharon M. Rymut et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2016)
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis
Amit Gaggar et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis
Laurent Meijer et al.
JOURNAL OF INNATE IMMUNITY (2016)
Key mechanisms governing resolution of lung inflammation
C. T. Robb et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
New and emerging targeted therapies for cystic fibrosis
Bradley S. Quon et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
New and emerging targeted therapies for cystic fibrosis
Bradley S. Quon et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
New Insights about miRNAs in Cystic Fibrosis
Florence Sonneville et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking
Graeme W. Carlile et al.
JOURNAL OF CYSTIC FIBROSIS (2015)
Genetic Deletion and Pharmacological Inhibition of PI3Kγ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease
Maria Galluzzo et al.
MEDIATORS OF INFLAMMATION (2015)
Respiratory epithelial cells orchestrate pulmonary innate immunity
Jeffrey A. Whitsett et al.
NATURE IMMUNOLOGY (2015)
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
C. E. Wainwright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
TRPC6 channel translocation into phagosomal membrane augments phagosomal function
Vladimir Riazanski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
Sonya L. Heltshe et al.
CLINICAL INFECTIOUS DISEASES (2015)
Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells
Maria Favia et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
Steven M. Rowe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy
Kerstin Pohl et al.
BLOOD (2014)
Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism
C. Norez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Leukocyte Migration into Inflamed Tissues
Sussan Nourshargh et al.
IMMUNITY (2014)
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis
M. W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Antibacterial properties of the CFTR potentiator ivacaftor
Leah R. Reznikov et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
Alan R. Smyth et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
GBA2-Encoded β-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa
Nicoletta Loberto et al.
PLOS ONE (2014)
Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis
William G. Flight et al.
THORAX (2014)
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
Michael P. Boyle et al.
LANCET RESPIRATORY MEDICINE (2014)
Cystic Fibrosis Pulmonary Guidelines Chronic Medications for Maintenance of Lung Health
Peter J. Mogayzel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
CDK inhibitors suppress Th17 and promote iTreg differentiation, and ameliorate experimental autoimmune encephalomyelitis in mice
Hideyuki Yoshida et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis
Richard B. Moss et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation
Ignacio J. Juncadella et al.
NATURE (2013)
Detection of Phospho- Sites Generated by Protein Kinase CK2 in CFTR: Mechanistic Aspects of Thr1471 Phosphorylation
Andrea Venerando et al.
PLOS ONE (2013)
Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients
Rogier A. S. Hoek et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Respiratory Syncytial Virus Infection Disrupts Monolayer Integrity and Function in Cystic Fibrosis Airway Cells
Michele Kong et al.
VIRUSES-BASEL (2013)
Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients
Benjamin T. Kopp et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa
Felix Ratjen et al.
CHEST (2012)
Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
Patrick A. Flume et al.
CHEST (2012)
A randomized placebo-controlled trial of miglustat in cystic fibrosis based on nasal potential difference
Anissa Leonard et al.
JOURNAL OF CYSTIC FIBROSIS (2012)
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation
J. P. Clancy et al.
THORAX (2012)
Trimethylangelicin reduces IL-8 transcription and potentiates CFTR function
Anna Tamanini et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Restoration of Chloride Efflux by Azithromycin in Airway Epithelial Cells of Cystic Fibrosis Patients
Vinciane Saint-Criq et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The role of matrix metalloproteinases in cystic fibrosis lung disease
A. Gaggar et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Implications of the innate immune response to adenovirus and adenoviral vectors
Seth M. Gregory et al.
FUTURE VIROLOGY (2011)
Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis
Laura Viviani et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Bonnie W. Ramsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
Reshma Amin et al.
CHEST (2010)
In Cystic Fibrosis Homozygotes and Heterozygotes, Neutrophil Apoptosis Is Delayed and Modulated by Diamide or Roscovitine: Evidence for an Innate Neutrophil Disturbance
Sandra Moriceau et al.
JOURNAL OF INNATE IMMUNITY (2010)
Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition
Alessandro Luciani et al.
NATURE CELL BIOLOGY (2010)
Cystic Fibrosis Fatty Acid Imbalance Is Linked to Ceramide Deficiency and Corrected by Fenretinide
Claudine Guilbault et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Alveolar macrophages and CC chemokines are increased in children with cystic fibrosis
S. Brennan et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Fenretinide corrects newly found ceramide deficiency in cystic fibrosis
Claudine Guilbault et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Anti-inflammatory Therapies for Cystic Fibrosis-Related Lung Disease
David P. Nichols et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2008)
Nonsteroidal anti-inflammatory drugs upregulate function of wild-type and mutant CFTR
J. Li et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Airway epithelial cell inflammatory signalling in cystic fibrosis
Jacky Jacquot et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Anti-inflammatory effect of miglustat in bronchial epithelial cells
Maria Cristina Dechecchi et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
The role of respiratory viruses in cystic fibrosis
Dennis Wat et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Prevalence and Impact of Respiratory Viral Infections in Young Children With Cystic Fibrosis: Prospective Cohort Study
Bart E. van Ewijk et al.
PEDIATRICS (2008)
Cystic fibrosis pulmonary guidelines - Chronic medications for maintenance of lung health
Patrick A. Flume et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial
Larry C. Lands et al.
JOURNAL OF PEDIATRICS (2007)
Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis
Xiaodong Wang et al.
CELL (2006)
Rescue of ΔF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules
F Van Goor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the α-glucosidase inhibitor miglustat
C Norez et al.
FEBS LETTERS (2006)
Corticosteroid effects on cell signalling
PJ Barnes
EUROPEAN RESPIRATORY JOURNAL (2006)
Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells
M Shinkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Resolution of inflammation: The beginning programs the end
CN Serhan et al.
NATURE IMMUNOLOGY (2005)
Early oral cysteamine therapy for nephropathic cystinosis
WA Gahl
EUROPEAN JOURNAL OF PEDIATRICS (2003)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Effect of ibuprofen on neutrophil migration in vivo in cystic fibrosis and healthy subjects
MW Konstan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal
K Lauber et al.
CELL (2003)
Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis
S Zheng et al.
IMMUNITY (2003)
Impact of respiratory viral infections on cystic fibrosis
D Wat
POSTGRADUATE MEDICAL JOURNAL (2003)
Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin
VH Lillelund et al.
CHEMICAL REVIEWS (2002)
Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H2 synthases by ibuprofen, naproxen, and indomethacin
MS Jaradat et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Ceramide-mediated apoptosis in lung epithelial cells is regulated by glutathione
SN Lavrentiadou et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
I Tegeder et al.
FASEB JOURNAL (2001)
Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application
N Asano et al.
TETRAHEDRON-ASYMMETRY (2000)
Ceramide path in human lung cell death
C Chan et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
